https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/akums-gets-dcgi-nod-for-triple-combination-diabetes-medication/102174933
0
0
47 words
0
Comments
Akums Drugs & Pharmaceuticals Joint Managing Director Sandeep Jain noted that the renoprotective effects of drugs like metformin, coupled with the functional and corrective influence of pioglitazone on beta-cell and metabolic syndrome and the stability of Sit…
You are the first to view
Create an account or login to join the discussion